Cue Biopharma, Inc. (CUE)
4.15
-0.35
(-7.78%)
USD |
NASDAQ |
Nov 20, 16:00
4.20
+0.05
(+1.20%)
After-Hours: 20:00
Cue Biopharma Cash and Short Term Investments (Annual) : 27.14M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 27.14M |
| December 31, 2024 | 22.46M |
| December 31, 2023 | 48.51M |
| December 31, 2022 | 76.29M |
| December 31, 2021 | 64.37M |
| December 31, 2020 | 84.87M |
| Date | Value |
|---|---|
| December 31, 2019 | 59.41M |
| December 31, 2018 | 39.26M |
| December 31, 2017 | 63.58M |
| December 31, 2016 | 14.98M |
| December 31, 2015 | 6.455M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Cypherpunk Technologies, Inc. | 14.04M |
| Yarrow Bioscience, Inc. | 29.01M |
| Faeth Therapeutics, Inc. | 21.18M |
| Indaptus Therapeutics, Inc. | 8.508M |
| Pyxis Oncology, Inc. | 68.33M |